Question
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($
Presented below are condensed financial statements adapted from those of two actual companies competing in the pharmaceutical industryJohnson and Johnson (J&J) and Pfizer, Inc. ($ in millions, except per share amounts).
Balance Sheets ($ in millions, except per share data) | |||||||
J&J | Pfizer | ||||||
Assets: | |||||||
Cash | $ | 12,687 | $ | 7,602 | |||
Short-term investments | 5,406 | 11,662 | |||||
Accounts receivable (net) | 8,024 | 10,225 | |||||
Inventories | 4,928 | 8,187 | |||||
Other current assets | 4,860 | 4,725 | |||||
Current assets | 35,905 | 42,401 | |||||
Property, plant, and equipment (net) | 13,406 | 21,847 | |||||
Intangibles and other assets | 17,982 | 71,307 | |||||
Total assets | $ | 67,293 | $ | 135,555 | |||
Liabilities and Shareholders' Equity: | |||||||
Accounts payable | $ | 6,316 | $ | 3,951 | |||
Short-term notes | 3,449 | 11,128 | |||||
Other current liabilities | 8,593 | 13,488 | |||||
Current liabilities | 18,358 | 28,567 | |||||
Long-term debt | 4,205 | 7,005 | |||||
Other long-term liabilities | 6,221 | 23,216 | |||||
Total liabilities | 28,784 | 58,788 | |||||
Capital stock (par and additional paid-in capital) | 4,620 | 68,550 | |||||
Retained earnings | 42,053 | 40,432 | |||||
Accumulated other comprehensive income (loss) | (790 | ) | 245 | ||||
Less: Treasury stock and other equity adjustments | (7,374 | ) | (32,460 | ) | |||
Total shareholders' equity | 38,509 | 76,767 | |||||
Total liabilities and shareholders' equity | $ | 67,293 | $ | 135,555 | |||
Income Statements | |||||||
Net sales | $ | 47,212 | $ | 50,538 | |||
Cost of goods sold | 13,436 | 11,092 | |||||
Gross profit | 33,776 | 39,446 | |||||
Operating expenses | 20,983 | 29,706 | |||||
Other (income) expensenet | (535 | ) | 3,760 | ||||
Income before taxes | 13,328 | 5,980 | |||||
Tax expense | 3,998 | 1,794 | |||||
Net income | $ | 9,330 | $ | 4,186 | * | ||
Basic net income per share | $ | 2.92 | $ | 0.72 | |||
* This is before income from discontinued operations. Evaluate and compare the two companies by responding to the following questions. Note: Because two-year comparative statements are not provided, you should use year-end balances in place of average balances as appropriate. Required: 1. For both companies, compute the ratios below.
This is before income from discontinued operations. Evaluate and compare the two companies by responding to the following questions. Note: Because two-year comparative statements are not provided, you should use year-end balances in place of average appropriate. Required: 1. For both companies, compute the ratios below. 2. Evaluate and compare the two companies. Complete this question by entering your answers in the tabs below. Required 2 Required 1 For both companies, compute the ratios below. J&J Pfizer Receivables Turnover (## #) Average Collection Period (#) Inventory Turnover (###) Average Days in Inventory (# Profit Margin (###)% Asset Turnover (## #) Return on Assets (##)% times days times days times days times days % % times times Equity Multiplier (### Return on Shareholders' Equity (##)% % % Required 2 Required 1Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started